BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//ACC//Meetings//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011101T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD BEGIN:DAYLIGHT DTSTART:16010301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION: \n\n\nWebinar Overview\nIn this webinar\, Alison Bailey\, MD\, FACC\, and Melvin R. Echols\, MD\, FACC\, review the evolution of the wor sening HF definition. Specifically\, they will highlight the nomenclature and epidemiology to ensure participants understand the importance of consi dering the onset of worsening HF as an event that marks a new phase of HF. This webinar is part of the Transform HF Care: New Horizons in Treatment initiative\, supported by Bayer AG. Visit the Managing HF Across the Spect rum online course and access additional educational activities here.\nKey Objectives/Learning Outcomes:\n\nEvaluate the epidemiology\, risk factors\ , comorbidities and community aspects associated with HF to determine best practices for care.\nDistinguish pathophysiologic characteristics when ev aluating and diagnosing HF\, including current classifications\, genotypes and phenotypes\, to analyze best HF risk stratification\, prevention and management strategies.\nIncorporate guideline-directed medical therapy (GD MT)\, newer therapies and interprofessional team strategies into treatment care plans for the management of HF to improve care coordination\, commun ication and patient outcomes.\n\n\nWebinar Recording\n\n\n-->\n\nWebinar P articipants\nAlison Bailey\, MD\, FACC\nMelvin R. Echols\, MD\, FACC\n\nCr edit Information\nNo credit is being offered for this webinar.\n\n\n\n\n\n .videoWrapper {\n position: relative\;\n padding-bottom: 56.25%\; /* 1 6:9 */\n padding-top: 25px\;\n height: 0\;\n }\n .videoWrapper iframe {\n position: absolute\;\n top: 0\;\n left: 0\;\n width: 100%\;\n hei ght: 100%\;\n }\n DTEND;TZID=Eastern Standard Time:20251120T183000 DTSTAMP:20260410T115007Z DTSTART;TZID=Eastern Standard Time:20251120T181500 LOCATION:Online - Eastern Time (ET) SEQUENCE:0 SUMMARY:The Nomenclature and Epidemiology of Worsening HF: What to Do UID:67588e11-4aaa-4a23-a078-e0a9578e4851@acc.org X-ALT-DESC;FMTTYPE=text/html:
\n
\n\n

Webinar Overv iew

\n

In this webinar\, Alison Baile y\, MD\, FACC\, and Melvin R. Echols\, MD\, FACC \, review the evolution of the worsening HF definition. Specifically\, the y will highlight the nomenclature and epidemiology to ensure participants understand the importance of considering the onset of worsening HF as an e vent that marks a new phase of HF. This webinar is part of the Tra nsform HF Care: New Horizons in Treatment initiative\, supported by Bayer AG. Visit the Managing HF Across the Spectrum onlin e course and access additional educational activities here.

\n

Key Objectives/Learning Outcomes:

\n
    \n
  1. Evaluate the epidemiology\, risk factors\, comorbiditi es and community aspects associated with HF to determine best practices fo r care.
    2. \n
  2. Distinguish pathophysiologic characteristics when evalua ting and diagnosing HF\, including current classifications\, genotypes and phenotypes\, to analyze best HF risk stratification\, prevention and mana gement strategies.
    3. \n
  3. Incorporate guideline-directed medical therap y (GDMT)\, newer therapies and interprofessional team strategies into trea tment care plans for the management of HF to improve care coordination\, c ommunication and patient outcomes.
    4. \n
\n\n\n\n

Webinar Participants

\n

Alison Bailey\, MD\, FACC
\nMelvin R. Echols\, MD\, FAC C

\n\n

Credit Information

\n

No credit is being offered for this webinar.

\n\n
\n\n
\n BEGIN:VALARM ACTION:Display DESCRIPTION:Reminder TRIGGER:-PT15M END:VALARM END:VEVENT END:VCALENDAR